FC
EBS icon

Financial Consulate’s Emergent Biosolutions EBS Stock Holding History

Financial Consulate’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445 Sell
53
-35
-40% -$293 ﹤0.01% 1358
2026
Q1 		$731 Hold
88
– – ﹤0.01% 1166
2025
Q4 		$1.09K Hold
88
– – ﹤0.01% 998
2025
Q3 		$777 Buy
+88
New +$684 ﹤0.01% 907

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Financial Consulate's EBS Position: Q2 2026 in Review

Financial Consulate reduced its Emergent Biosolutions (EBS) stake by 40% in Q2 2026, selling an estimated $293 and leaving 53 shares worth $445. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Financial Consulate first reported a position in EBS in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.09K in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Financial Consulate held 53 shares of Emergent Biosolutions worth $445 as of Q2 2026.
  • Financial Consulate sold 35 Emergent Biosolutions shares in Q2 2026, an estimated $293.
  • Emergent Biosolutions made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1358 holding.
  • Financial Consulate first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's Emergent Biosolutions position peaked at $1.09K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.